FDA Accepts LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s …

If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for ...

Saudi Arabia Foodservice Disposable Packaging Market 2026-2031: Saudi Arabia's QSR Expansion Drives Surge in Disposable Packaging Market

Demand for unit-dose packs, tamper-evident formats, and compostable materials is risingDublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Saudi Arabia Foodservice Disposable Packaging - Market Share ...

RSSB recruitment 2026: LDC, forester and CET-based posts draw over 2.7 lakh applications for 13,362 vacancies; check details here

Rajasthan Staff Selection Board is seeing massive interest in ongoing recruitments, with over 2.7 lakh applications across ...
Investopedia

Artificial Intelligence (AI): What It Is, How It Works, Types, and Uses

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Gordon Scott has been an active investor and ...
MyHorryNews

FDA Accepts LEQEMBI® IQLIKTM (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under ...

If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and maintenance dosing for this progressive, relentless disease ...